Progresses on genetics of predementia phase of Alzheimer's disease

Progress in Biochemistry and Biophysics

Volumn 39, Issue 8, 2012, Pages 698-702

  Jia, Jian Ping ^a   Wang, Fen ^a   Yuan, Quan ^a   Qin, Wei ^a   Tnag, Yi ^a   Zuo, Xiu Mei ^a   Han, Yue ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Genetics; MCI; Polymorphism; Pre dementia phase

Indexed keywords

EID: 84870866811     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2012.00210     Document Type: Review

References (32)

1. Sperling R A, Aisen P S, Beckett L A, et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the national institute on aging-alzheimet's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 2011, 7( 3): 280-292
2. Morris J C. Early-stage and preclinical Alzheimer disease. Alzheimer Dis Assoc Disord, 2005, 19(3): 163-165 (Pubitemid 41545853)
3. Tervo S, Kivipelto M, Hanninen T, et al. Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord, 2004, 17(3): 196-203 (Pubitemid 38339747)
4. Barabash A, Marcos A, Ancin I, et al. APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease. Neurobiol Aging, 2009, 30( 8): 1254-1264
5. Lopez O L, Jagust W J, Dulberg C, et al. Risk factors for mild cognitive impairment in the cardiovascular health study cognition study: part 2. Arch Neurol, 2003, 60(10): 1394-1399 (Pubitemid 37248800)
6. Hashimoto R, Hirata Y, Asada T, et al. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease. Genes Brain Behav, 2009, 8( 1): 43-52
7. Petersen R C, Smith G E, Ivnik R J, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA, 1995, 273( 16): 1274-1278
8. Lautenschlager N T, Flicker L, Vasikaran S, et al. Subjective memory complaints with and without objective memory impairment: relationship with risk factors for dementia. Am J Geriatr Psychiatry, 2005, 13(8): 731-734 (Pubitemid 41197245)
9. Heun R, Guhne U, Luck T, et al. Apolipoprotein E allele 4 is not a sufficient or a necessary predictor of the development of mild cognitive impairment. Eur Psychiatry, 2010, 25( 1): 15-18
10. Fu B Y, Ma S L, Tang N L, et al. Cholesterol 24-hydroxylase (CYP46A1) polymorphisms are associated with faster cognitive deterioration in Chinese older persons: A two-year follow up study. Int J Geriatr Psychiatry, 2009, 24( 9): 921-926
11. Kamboh M I, Sanghera D K, Ferrell R E, et al. APOE allele epsilon 4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nat Genet, 1995, 10( 4): 486-488
12. Morgan K, Morgan L, Carpenter K, et al. Microsatellite polymorphism of the alpha 1-antichymotrypsin gene locus associated with sporadic Alzheimer's disease. Hum Genet, 1997, 99(1): 27-31 (Pubitemid 26419849)
13. Muller U, Bodeker R H, Gerundt I, et al. Lack of association between alpha 1-antichymotrypsin polymorphism, Alzheimer's disease, and allele epsilon 4 of apolipoprotein E. Neurology, 1996, 47(6): 1575-1577 (Pubitemid 26422558)
14. Tang M, Rao D, Ma C, et al. Evaluation of choline acetyltransferase gene polymorphism (2384 G/A) in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord, 2008, 26( 1): 9-14
15. DeKosky S T, Ikonomovic M D, Styren S D, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol, 2002, 51(2): 145-155 (Pubitemid 34111436)
16. Richard F, Amouyel P. Genetic susceptibility factors for Alzheimer's disease. Eur J Pharmacol, 2001, 412(1): 1-12 (Pubitemid 32149763)
17. Farrer L A, Cupples L A, Haines J L, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA, 1997, 278(16): 1349-1356 (Pubitemid 27449696)
18. Bertram L, McQueen M B, Mullin K, et al. Systematic metaanalyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet, 2007, 39(1): 17-23 (Pubitemid 46026496)
19. Rogaeva E, Meng Y, Lee J H, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet, 2007, 39(2): 168-177 (Pubitemid 46184347)
20. Tan E K, Lee J, Chen C P, et al. SORL1 haplotypes modulate risk of Alzheimet's disease in Chinese. Neurobiol Aging, 2009, 30( 7): 1048-1051
21. Ikram M A, Liu F, Oostra B A, et al. The GAB2 gene and the risk of Alzheimer's disease: Replication and meta- analysis. Biol Psychiatry, 2009, 65( 11): 995-999
22. Elkins J S, Douglas V C, Johnston S C. Alzheimer disease risk and genetic variation in ACE: a meta-analysis. Neurology, 2004, 62(3): 363-368 (Pubitemid 38200844)
23. Balbin M, Abrahamson M. Sstll polymorphic sites in the promoter region of the human cystatin C gene. Hum Genet, 1991, 87( 6): 751-752
24. Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet, 2009, 41 ( 10): 1088-1093
25. Naj A C, Jun G, Beecham G W, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHAl are associated with late-onset Alzheimer's disease. Nat Genet, 2011, 43( 5): 436-441
26. Reiman E M, Webster J A, Myers A J, et al. GAB2 alleles modify Alzheimet's risk in APOE epsilon4 carriers. Neuron, 2007, 54(5): 713-720 (Pubitemid 46843528)
27. Bertram L, Lange C, Mullin K, et al. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet, 2008, 83( 5): 623-632
28. Carrasquillo M M, Zou F, Pankratz V S, et al. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nat Genet, 2009, 41( 2): 192-198
29. Delay C, Calon F, Mathews P, et al. Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function. Mol Neurodegener, 2011, 6: 70
30. Wang S, Jia J. Promoter polymorphisms which modulate BACE1 expression are associated with sporadic Alzheimers disease. Am J Med Genet B Neuropsychiatr Genet, 2010, 153B( 1): 159-166
31. Cong L, Jia J. Promoter polymorphisms which regulate ADAM9 transcription are protective against sporadic Alzheimer's disease. Neurobiol Aging, 2011, 32( 1): 54-62
32. Zhou J W. Recent progress in neurodegenerative disorder research in China. Sci China Life Sci, 2010, 53( 3): 348-355